Chelsea Therapeutics soars as FDA panel backs key drug

Posted on February 24, 2012 by admin

(Reuters) – Shares of Chelsea Therapeutics International Ltd rose as much as 76 percent on Friday after a committee of independent experts recommended the approval of its hypotension drug in the…

This entry was posted in News and tagged , , , , , . Bookmark the permalink.

 

Our keys

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>